Global Polio Vaccine Market Growth 2020-2025

Publisher Name :
Date: 23-Sep-2020
No. of pages: 135

According to this study, over the next five years the Polio Vaccine market will register a 5.5%% CAGR in terms of revenue, the global market size will reach $ 1638.1 million by 2025, from $ 1322.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Polio Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Polio Vaccine, covering the supply chain analysis, impact assessment to the Polio Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Polio Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Inactivated Polio Vaccine (IPV)

- Oral Polio Vaccine (OPV)

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Public

- Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Sanofi

- GSK

- Serum Institute

- Tiantan Biological

- Bibcol

- Bio-Med

- IMBCA

- Halfkin Bio-Pharmaceuticals

- Panacea Biotec Ltd

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Polio Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Polio Vaccine market by identifying its various subsegments.

- Focuses on the key global Polio Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Polio Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Polio Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Polio Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polio Vaccine Consumption 2015-2025
2.1.2 Polio Vaccine Consumption CAGR by Region
2.2 Polio Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Polio Vaccine Consumption by Type
2.3.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Polio Vaccine Sale Price by Type (2015-2020)
2.4 Polio Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Polio Vaccine Consumption by Application
2.5.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Polio Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Polio Vaccine Sale Price by Type (2015-2020)

3 Global Polio Vaccine by Company
3.1 Global Polio Vaccine Sales Market Share by Company
3.1.1 Global Polio Vaccine Sales by Company (2018-2020)
3.1.2 Global Polio Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Polio Vaccine Revenue Market Share by Company
3.2.1 Global Polio Vaccine Revenue by Company (2018-2020)
3.2.2 Global Polio Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Polio Vaccine Sale Price by Company
3.4 Global Polio Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Polio Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Polio Vaccine by Regions
4.1 Polio Vaccine by Regions
4.2 Americas Polio Vaccine Consumption Growth
4.3 APAC Polio Vaccine Consumption Growth
4.4 Europe Polio Vaccine Consumption Growth
4.5 Middle East & Africa Polio Vaccine Consumption Growth

5 Americas
5.1 Americas Polio Vaccine Consumption by Countries
5.1.1 Americas Polio Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Polio Vaccine Value by Countries (2015-2020)
5.2 Americas Polio Vaccine Consumption by Type
5.3 Americas Polio Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Polio Vaccine Consumption by Regions
6.1.1 APAC Polio Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Polio Vaccine Value by Regions (2015-2020)
6.2 APAC Polio Vaccine Consumption by Type
6.3 APAC Polio Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Polio Vaccine by Countries
7.1.1 Europe Polio Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Polio Vaccine Value by Countries (2015-2020)
7.2 Europe Polio Vaccine Consumption by Type
7.3 Europe Polio Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Polio Vaccine by Countries
8.1.1 Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Polio Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Polio Vaccine Consumption by Type
8.3 Middle East & Africa Polio Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Polio Vaccine Distributors
10.3 Polio Vaccine Customer

11 Global Polio Vaccine Market Forecast
11.1 Global Polio Vaccine Consumption Forecast (2021-2025)
11.2 Global Polio Vaccine Forecast by Regions
11.2.1 Global Polio Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Polio Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Polio Vaccine Forecast by Type
11.8 Global Polio Vaccine Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Information
12.1.2 Polio Vaccine Product Offered
12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Polio Vaccine Product Offered
12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 Serum Institute
12.3.1 Company Information
12.3.2 Polio Vaccine Product Offered
12.3.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Serum Institute Latest Developments
12.4 Tiantan Biological
12.4.1 Company Information
12.4.2 Polio Vaccine Product Offered
12.4.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Tiantan Biological Latest Developments
12.5 Bibcol
12.5.1 Company Information
12.5.2 Polio Vaccine Product Offered
12.5.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bibcol Latest Developments
12.6 Bio-Med
12.6.1 Company Information
12.6.2 Polio Vaccine Product Offered
12.6.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bio-Med Latest Developments
12.7 IMBCA
12.7.1 Company Information
12.7.2 Polio Vaccine Product Offered
12.7.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 IMBCA Latest Developments
12.8 Halfkin Bio-Pharmaceuticals
12.8.1 Company Information
12.8.2 Polio Vaccine Product Offered
12.8.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Halfkin Bio-Pharmaceuticals Latest Developments
12.9 Panacea Biotec Ltd
12.9.1 Company Information
12.9.2 Polio Vaccine Product Offered
12.9.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Panacea Biotec Ltd Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Polio Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Inactivated Polio Vaccine (IPV)
Table 5. Major Players of Oral Polio Vaccine (OPV)
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Polio Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Polio Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Polio Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Polio Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Polio Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Polio Vaccine Value by Application (2015-2020)
Table 14. Global Polio Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Polio Vaccine Sale Price by Application (2015-2020)
Table 16. Global Polio Vaccine Sales by Company (2017-2019) (M Doses)
Table 17. Global Polio Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Polio Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Polio Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Polio Vaccine Sale Price by Company (2017-2019)
Table 21. Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Polio Vaccine Products Offered
Table 23. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Polio Vaccine Consumption by Regions 2015-2020 (M Doses)
Table 25. Global Polio Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Polio Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Polio Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Polio Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 29. Americas Polio Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Polio Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Polio Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Polio Vaccine Consumption by Type (2015-2020) (M Doses)
Table 33. Americas Polio Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Polio Vaccine Consumption by Application (2015-2020) (M Doses)
Table 35. Americas Polio Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Polio Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 37. APAC Polio Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Polio Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Polio Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Polio Vaccine Consumption by Type (2015-2020) (M Doses)
Table 41. APAC Polio Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Polio Vaccine Consumption by Application (2015-2020) (M Doses)
Table 43. APAC Polio Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Polio Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 45. Europe Polio Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Polio Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Polio Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Polio Vaccine Consumption by Type (2015-2020) (M Doses)
Table 49. Europe Polio Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Polio Vaccine Consumption by Application (2015-2020) (M Doses)
Table 51. Europe Polio Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 53. Middle East & Africa Polio Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Polio Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Polio Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Polio Vaccine Consumption by Type (2015-2020) (M Doses)
Table 57. Middle East & Africa Polio Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Polio Vaccine Consumption by Application (2015-2020) (M Doses)
Table 59. Middle East & Africa Polio Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Polio Vaccine Distributors List
Table 61. Polio Vaccine Customer List
Table 62. Global Polio Vaccine Consumption Forecast by Countries (2021-2025) (M Doses)
Table 63. Global Polio Vaccine Consumption Market Forecast by Regions
Table 64. Global Polio Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Polio Vaccine Value Market Share Forecast by Regions
Table 66. Global Polio Vaccine Consumption Forecast by Type (2021-2025) (M Doses)
Table 67. Global Polio Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Polio Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Polio Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Polio Vaccine Consumption Forecast by Application (2021-2025) (M Doses)
Table 71. Global Polio Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Polio Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Polio Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. Sanofi Product Offered
Table 75. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. Sanofi Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Product Offered
Table 80. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. GSK Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Serum Institute Product Offered
Table 85. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 86. Serum Institute Main Business
Table 87. Serum Institute Latest Developments
Table 88. Serum Institute Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Tiantan Biological Product Offered
Table 90. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 91. Tiantan Biological Main Business
Table 92. Tiantan Biological Latest Developments
Table 93. Tiantan Biological Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Bibcol Product Offered
Table 95. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 96. Bibcol Main Business
Table 97. Bibcol Latest Developments
Table 98. Bibcol Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Bio-Med Product Offered
Table 100. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 101. Bio-Med Main Business
Table 102. Bio-Med Latest Developments
Table 103. Bio-Med Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. IMBCA Product Offered
Table 105. IMBCA Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. IMBCA Main Business
Table 107. IMBCA Latest Developments
Table 108. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 109. Halfkin Bio-Pharmaceuticals Product Offered
Table 110. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 111. Halfkin Bio-Pharmaceuticals Main Business
Table 112. Halfkin Bio-Pharmaceuticals Latest Developments
Table 113. Halfkin Bio-Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Panacea Biotec Ltd Product Offered
Table 115. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 116. Panacea Biotec Ltd Main Business
Table 117. Panacea Biotec Ltd Latest Developments
Table 118. Panacea Biotec Ltd Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Polio Vaccine
Figure 2. Polio Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Polio Vaccine Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Polio Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 7. Product Picture of Oral Polio Vaccine (OPV)
Figure 8. Global Polio Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Polio Vaccine Value Market Share by Type (2015-2020)
Figure 10. Polio Vaccine Consumed in Public
Figure 11. Global Polio Vaccine Market: Public (2015-2020) (M Doses)
Figure 12. Global Polio Vaccine Market: Public (2015-2020) ($ Millions)
Figure 13. Polio Vaccine Consumed in Private
Figure 14. Global Polio Vaccine Market: Private (2015-2020) (M Doses)
Figure 15. Global Polio Vaccine Market: Private (2015-2020) ($ Millions)
Figure 16. Global Polio Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global Polio Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global Polio Vaccine Sales Market Share by Company in 2017
Figure 19. Global Polio Vaccine Sales Market Share by Company in 2019
Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2017
Figure 21. Global Polio Vaccine Revenue Market Share by Company in 2019
Figure 22. Global Polio Vaccine Sale Price by Company in 2019
Figure 23. Global Polio Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global Polio Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas Polio Vaccine Consumption 2015-2020 (M Doses)
Figure 26. Americas Polio Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC Polio Vaccine Consumption 2015-2020 (M Doses)
Figure 28. APAC Polio Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe Polio Vaccine Consumption 2015-2020 (M Doses)
Figure 30. Europe Polio Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Polio Vaccine Consumption 2015-2020 (M Doses)
Figure 32. Middle East & Africa Polio Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas Polio Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas Polio Vaccine Value Market Share by Countries in 2019
Figure 35. Americas Polio Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas Polio Vaccine Consumption Market Share by Application in 2019
Figure 37. United States Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 38. United States Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 40. Canada Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 42. Mexico Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Polio Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC Polio Vaccine Value Market Share by Regions in 2019
Figure 45. APAC Polio Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC Polio Vaccine Consumption Market Share by Application in 2019
Figure 47. China Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 48. China Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 50. Japan Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 52. Korea Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 54. Southeast Asia Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 56. India Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 58. Australia Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Polio Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe Polio Vaccine Value Market Share by Countries in 2019
Figure 61. Europe Polio Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe Polio Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 64. Germany Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 66. France Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 68. UK Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 70. Italy Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 72. Russia Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Polio Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Polio Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Polio Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Polio Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 78. Egypt Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 80. South Africa Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 82. Israel Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 84. Turkey Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Polio Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 86. GCC Countries Polio Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Polio Vaccine Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 88. Global Polio Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 90. Americas Polio Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 92. APAC Polio Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 94. Europe Polio Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 96. Middle East & Africa Polio Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 98. United States Polio Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 100. Canada Polio Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 102. Mexico Polio Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 104. Brazil Polio Vaccine Value 2021-2025 ($ Millions)
Figure 105. China Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 106. China Polio Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 108. Japan Polio Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 110. Korea Polio Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 112. Southeast Asia Polio Vaccine Value 2021-2025 ($ Millions)
Figure 113. India Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 114. India Polio Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 116. Australia Polio Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 118. Germany Polio Vaccine Value 2021-2025 ($ Millions)
Figure 119. France Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 120. France Polio Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 122. UK Polio Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 124. Italy Polio Vaccine Value 2021-2025 ($ Millions)
Figure 125. Russia Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 126. Russia Polio Vaccine Value 2021-2025 ($ Millions)
Figure 127. Spain Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 128. Spain Polio Vaccine Value 2021-2025 ($ Millions)
Figure 129. Egypt Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 130. Egypt Polio Vaccine Value 2021-2025 ($ Millions)
Figure 131. South Africa Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 132. South Africa Polio Vaccine Value 2021-2025 ($ Millions)
Figure 133. Israel Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 134. Israel Polio Vaccine Value 2021-2025 ($ Millions)
Figure 135. Turkey Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 136. Turkey Polio Vaccine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Polio Vaccine Consumption 2021-2025 (M Doses)
Figure 138. GCC Countries Polio Vaccine Value 2021-2025 ($ Millions)
Figure 139. Sanofi Polio Vaccine Market Share (2018-2020)
Figure 140. GSK Polio Vaccine Market Share (2018-2020)
Figure 141. Serum Institute Polio Vaccine Market Share (2018-2020)
Figure 142. Tiantan Biological Polio Vaccine Market Share (2018-2020)
Figure 143. Bibcol Polio Vaccine Market Share (2018-2020)
Figure 144. Bio-Med Polio Vaccine Market Share (2018-2020)
Figure 145. IMBCA Polio Vaccine Market Share (2018-2020)
Figure 146. Halfkin Bio-Pharmaceuticals Polio Vaccine Market Share (2018-2020)
Figure 147. Panacea Biotec Ltd Polio Vaccine Market Share (2018-2020)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs